Chronic Viral Hepatitis: Current Management and Future Directions

Albert Do, Nancy S. Reau – 20 January 2020 – The past decade has seen transformation in the strategies for identifying and managing viral hepatitis, most dramatically the transformation of hepatitis C virus from a mostly chronic affliction to a curable disease that is accessible to wide populations through direct‐acting antiviral therapies. More recently, shifting of hepatitis C virus burden to younger patients driven by intravenous drug use has shaped screening recommendations.

Transmission of Rat Hepatitis E Virus Infection to Humans in Hong Kong: A Clinical and Epidemiological Analysis

Siddharth Sridhar, Cyril Chik‐Yan Yip, Shusheng Wu, Nicholas Foo‐Siong Chew, Kit‐Hang Leung, Jasper Fuk‐Woo Chan, Pyrear Suhui Zhao, Wan‐Mui Chan, Rosana Wing‐Shan Poon, Hoi‐Wah Tsoi, Jian‐Piao Cai, Helen Shuk‐Ying Chan, Anthony Wai‐Shing Leung, Cindy Wing‐Sze Tse, Jonpaul Sze‐Tsing Zee, Owen Tak‐Yin Tsang, Vincent Chi‐Chung Cheng, Susanna Kar‐Pui Lau, Patrick Chiu‐Yat Woo, Dominic Ngai‐Chong Tsang, Kwok‐Yung Yuen – 20 January 2020

Indole Alleviates Diet‐Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6‐Phosphofructo‐2‐Kinase/Fructose‐2,6‐Biphosphatase 3

Linqiang Ma, Honggui Li, Jinbo Hu, Juan Zheng, Jing Zhou, Rachel Botchlett, Destiny Matthews, Tianshu Zeng, Lulu Chen, Xiaoqiu Xiao, Giri Athrey, David W. Threadgill, Qingsheng Li, Shannon Glaser, Heather Francis, Fanyin Meng, Qifu Li, Gianfranco Alpini, Chaodong Wu – 17 January 2020

Subscribe to